A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults with Asthma

Trial Identifier: D6830C00004
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: January 2025
Primary Completion Date: June 2025
Study Completion Date: June 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
DE Ahrensburg, DE, 22926
DE Berlin, DE, 10119
DE Mainz, DE, 55128